Literature DB >> 11192082

The first water-soluble 3(10)-helical peptides.

F Formaggio1, M Crisma, P Rossi, P Scrimin, B Kaptein, Q B Broxterman, J Kamphuis, C Toniolo.   

Abstract

Two water-soluble 3(10)-helical peptides are synthesized and fully characterized for the first time. The sequence of these terminally blocked heptamers comprises two residues of the Calpha-trisubstituted alpha-amino acid 2-amino-3-[1-(1,4,7-triazacyclononyl)]propanoic acid and five residues of a Calpha-tetrasubstituted alpha-amino acid (either alpha-aminoisobutyric acid or isovaline). Using CD and NMR techniques we were able to show that both heptapeptides are well structured in water, and that the type of conformation adopted is indeed the ternary 3(10)-helix.

Entities:  

Year:  2000        PMID: 11192082     DOI: 10.1002/1521-3765(20001215)6:24<4498::aid-chem4498>3.0.co;2-4

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  11 in total

1.  Ambidextrous helical nanotubes from self-assembly of designed helical hairpin motifs.

Authors:  Spencer A Hughes; Fengbin Wang; Shengyuan Wang; Mark A B Kreutzberger; Tomasz Osinski; Albina Orlova; Joseph S Wall; Xiaobing Zuo; Edward H Egelman; Vincent P Conticello
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

2.  Stereocontrolled Synthesis of Quaternary β,γ-Unsaturated Amino Acids: Chain Extension of D- & L- α-(2-Tributylstannyl)Vinyl Amino Acids.

Authors:  David B Berkowitz; Esmort Chisowa; Jill M McFadden
Journal:  Tetrahedron       Date:  2001-07-23       Impact factor: 2.457

3.  A peptide template as an allosteric supramolecular catalyst for the cleavage of phosphate esters.

Authors:  Alessandro Scarso; Ute Scheffer; Michael Göbel; Quirinus B Broxterman; Bernard Kaptein; Fernando Formaggio; Claudio Toniolo; Paolo Scrimin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

4.  De novo design of discrete, stable 310-helix peptide assemblies.

Authors:  Prasun Kumar; Neil G Paterson; Jonathan Clayden; Derek N Woolfson
Journal:  Nature       Date:  2022-06-22       Impact factor: 69.504

5.  An Ancestral Tryptophanyl-tRNA Synthetase Precursor Achieves High Catalytic Rate Enhancement without Ordered Ground-State Tertiary Structures.

Authors:  Paul J Sapienza; Li Li; Tishan Williams; Andrew L Lee; Charles W Carter
Journal:  ACS Chem Biol       Date:  2016-04-07       Impact factor: 5.100

6.  Facile biofunctionalization of silver nanoparticles for enhanced antibacterial properties, endotoxin removal, and biofilm control.

Authors:  Paramesh Ramulu Lambadi; Tarun Kumar Sharma; Piyush Kumar; Priyanka Vasnani; Sitaramanjaneya Mouli Thalluri; Neha Bisht; Ranjana Pathania; Naveen Kumar Navani
Journal:  Int J Nanomedicine       Date:  2015-03-18

7.  Systematic Design and Validation of Ion Channel Stabilization of Amphipathic α-Helical Peptides Incorporating Tryptophan Residues.

Authors:  Keita Shigedomi; Satoshi Osada; Masoud Jelokhani-Niaraki; Hiroaki Kodama
Journal:  ACS Omega       Date:  2020-12-29

8.  Total Synthesis and Conformational Analysis of Naturally Occurring Lipovelutibols along with Lead Optimization of Lipovelutibol D.

Authors:  Varun Pratap Singh; Anup Singh Pathania; Sonia Sharma; Fayaz Ahmed Malik; Anil Kumar; Deepika Singh; Ram A Vishwakarma
Journal:  ACS Omega       Date:  2021-02-26

9.  The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach.

Authors:  Annalisa Dalzini; Christian Bergamini; Barbara Biondi; Marta De Zotti; Giacomo Panighel; Romana Fato; Cristina Peggion; Marco Bortolus; Anna Lisa Maniero
Journal:  Sci Rep       Date:  2016-04-04       Impact factor: 4.379

10.  Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide.

Authors:  María J Gomara; Yolanda Perez; Patricia Gomez-Gutierrez; Carolina Herrera; Paul Ziprin; Javier P Martinez; Andreas Meyerhans; Juan J Perez; Isabel Haro
Journal:  Sci Rep       Date:  2020-09-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.